CardioSolv Ablation Technologies Overview
- Founded
-
2009

- Status
-
Private
- Employees
-
5

- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$669K
- Investors
-
5
CardioSolv Ablation Technologies General Information
Description
Developer of cardiac modeling and simulation technologies designed to treat patients suffering from arrhythmia. The company's technologies improve outcomes for patients who undergo ventricular tachycardia ablation procedures and reduce the procedure time and cost, enabling healthcare practitioners to improve the lives of the patients.
Contact Information
Website
www.cardiosolv.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Other Healthcare Services
Primary Office
- 2443 Maryland Avenue
- Baltimore, MD 21218
- United States
+1 (443) 000-0000
CardioSolv Ablation Technologies Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Grant | 01-Jan-2019 | $669K | 0000 | Completed | Generating Revenue | |
4. Later Stage VC | 24-Feb-2017 | 0000 | 0000 | Completed | Generating Revenue | |
3. Grant | 01-Jul-2015 | 00.000 | Completed | Generating Revenue | ||
2. Accelerator/Incubator | 27-Aug-2014 | Completed | Generating Revenue | |||
1. Early Stage VC | Completed | Startup |
CardioSolv Ablation Technologies Patents
CardioSolv Ablation Technologies Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20200273170-A1 | Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuit | Pending | 03-Dec-2015 | 000000000 | |
US-20170161896-A1 | Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuits | Granted | 03-Dec-2015 | 0000000000 | |
US-10679348-B2 | Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuit | Active | 03-Dec-2015 | 0000000000 | |
US-10402966-B2 | Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuits | Active | 03-Dec-2015 | 0000000000 | |
US-20190378272-A1 | Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuit | Granted | 03-Dec-2015 | G06T7/0012 |
CardioSolv Ablation Technologies Executive Team (7)
CardioSolv Ablation Technologies Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
Brock Tice Ph.D | CardioSolv Ablation Technologies | Co-Founder, Head of Technology & Board Member | 000 0000 |
Natalia Trayanova Ph.D | CardioSolv Ablation Technologies | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |
Scott Kokones | CardioSolv Ablation Technologies | Chief Operating Officer & Board Member | 000 0000 |
Steven Girouard Ph.D | Self | Board Member | 000 0000 |
Vincent Owens | Self | Co-Founder, Chief Executive Officer, President & Chairman | 000 0000 |
CardioSolv Ablation Technologies Signals
CardioSolv Ablation Technologies Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
National Institutes of Health | Government | 000 0000 | 000000 0 | ||
TEDCO | Venture Capital | Minority | 000 0000 | 000000 0 | |
U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | ||
Johns Hopkins Technology Ventures | Accelerator/Incubator | 000 0000 | 000000 0 | ||
Guide Medical Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |